Pyrrolizidine alkaloids (PAs) are hepatotoxic and carcinogenic alkaloids produced by Senecio and a number of other plant genera. Humans are exposed to PAs through ingestion of herbal teas, honey from bees or milk from cows or goats foraging on plants such as tansy ragwort (Senecio jacobaea). PAs undergo two major routes of metabolism, dehydrogenation to the toxic pyrrole derivative, dehydroretronecine (DHP), or N-oxidation which yields a detoxicated metabolite. These reactions have been ascribed to the cytochrome P-450-dependent mixed-function oxidase (mfo) system. Mammalian species vary widely in their susceptibility to PAs. Rats are quite susceptible, whereas, guinea pigs and rabbits are relatively resistant. Epidemiological evidence and accidental poisoning incidences strongly suggest that humans are very susceptible to PA-induced toxicity. The degree of susceptibility within a species, such as the rat, is strongly influenced by age, sex and previous exposure to environmental xenobiotics. The mechanism for such differences in sensitivity appears to be due to alterations in levels of the various monooxygenases. In this study, we will compare the metabolism of various PAs in vitro and in vivo in rat, rabbit and guinea pig. We will then examine the properties of different isozymes of cytochrome P-450 involved in DHP and N-oxide formation and investigate the existence, as well as the catalytic mechanism of formation, of other PA metabolites. In addition, the role of the less-studied flavin- containing monooxygenase (FMO) in PA N-oxiodation will be examined. These monooxygenases will be purified and their polyclonal antibodies utilized to assess the role of the individual enzymes in PA metabolism and to relate activity to changes in the amount of the protein (determined by immunoquantitation) as regulated by development and xenobiotic exposure. The activities and amounts of these monooxygenases will be related to the in vivo formation of covalent adducts of DNA, following administration of PAs. Human liver samples will also be analyzed for PA metabolism and the role played by individual monooxygenases studied, in order to compare humans to the animal models. These experiments are designed to ultimately provide us with an understanding of the genetic, developmental and environmental factors which determine the metabolic disposition of PAs and, hence, their toxicity. Such knowledge can be used to predict the relative risk of individuals and human populations to PAs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA022524-11
Application #
3165834
Study Section
Toxicology Study Section (TOX)
Project Start
1977-07-01
Project End
1991-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
11
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Oregon State University
Department
Type
Earth Sciences/Resources
DUNS #
053599908
City
Corvallis
State
OR
Country
United States
Zip Code
97339
Chung, Woon-Gye; Buhler, Donald R (2004) Differential metabolism of the pyrrolizidine alkaloid, senecionine, in Fischer 344 and Sprague-Dawley rats. Arch Pharm Res 27:547-53
Chung, W G; Buhler, D R (1995) Major factors for the susceptibility of guinea pig to the pyrrolizidine alkaloid jacobine. Drug Metab Dispos 23:1263-7
Chung, W G; Miranda, C L; Buhler, D R (1995) A cytochrome P4502B form is the major bioactivation enzyme for the pyrrolizidine alkaloid senecionine in guinea pig. Xenobiotica 25:929-39
Chung, W G; Buhler, D R (1994) The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs. Toxicol Appl Pharmacol 127:314-9
Reed, R L; Miranda, C L; Kedzierski, B et al. (1992) Microsomal formation of a pyrrolic alcohol glutathione conjugate of the pyrrolizidine alkaloid senecionine. Xenobiotica 22:1321-7
Miranda, C L; Reed, R L; Guengerich, F P et al. (1991) Role of cytochrome P450IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver. Carcinogenesis 12:515-9
Miranda, C L; Chung, W; Reed, R E et al. (1991) Flavin-containing monooxygenase: a major detoxifying enzyme for the pyrrolizidine alkaloid senecionine in guinea pig tissues. Biochem Biophys Res Commun 178:546-52
Williams, D E; Reed, R L; Kedzierski, B et al. (1989) The role of flavin-containing monooxygenase in the N-oxidation of the pyrrolizidine alkaloid senecionine. Drug Metab Dispos 17:380-6
Williams, D E; Reed, R L; Kedzierski, B et al. (1989) Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver. Drug Metab Dispos 17:387-92
Reed, R L; Ahern, K G; Pearson, G D et al. (1988) Crosslinking of DNA by dehydroretronecine, a metabolite of pyrrolizidine alkaloids. Carcinogenesis 9:1355-61

Showing the most recent 10 out of 17 publications